Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to -$7000.0.

  • Ironwood Pharmaceuticals' Gains from Investment Securities changed N/A to -$7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 2724.98%. This contributed to the annual value of $12.6 million for FY2024, which is 11599.55% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Gains from Investment Securities of -$7000.0 as of Q3 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Gains from Investment Securities peaked at $10.0 million during Q4 2023, and registered a low of -$5.6 million during Q3 2021.
  • In the last 5 years, Ironwood Pharmaceuticals' Gains from Investment Securities had a median value of -$13000.0 in 2023 and averaged $870642.9.
  • In the last 5 years, Ironwood Pharmaceuticals' Gains from Investment Securities plummeted by 19499.2% in 2021 and then soared by 334210.53% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Gains from Investment Securities (Quarter) stood at -$4.2 million in 2021, then surged by 242.1% to $5.9 million in 2022, then soared by 68.03% to $10.0 million in 2023, then decreased by 23.01% to $7.7 million in 2024, then crashed by 100.09% to -$7000.0 in 2025.
  • Its Gains from Investment Securities stands at -$7000.0 for Q3 2025, versus $7.7 million for Q4 2024 and $121000.0 for Q2 2024.